Literature DB >> 1504809

The effects of ibotenate lesions of the median preoptic nucleus on experimentally-induced and circadian drinking behavior in rats.

J T Cunningham1, T Beltz, R F Johnson, A K Johnson.   

Abstract

Male Sprague-Dawley rats were injected with either ibotenic acid or vehicle in the region of the median preoptic nucleus (MnPO) during methoxyflurane anesthesia. Later, the rats were tested for drinking responses elicited by angiotensin II (1 and 2 mg/kg s.c.) and hypertonic saline (3 and 6% w/v s.c.). Tests were conducted at 3 different phases of a 12:12 light-dark (LD) cycle (in the middle of the light phase and in the early and midportion of the dark phase). The rats with ibotenate lesions of the MnPO drank significantly less than vehicle-injected and lesion control groups regardless of when the tests were conducted. Subsequent monitoring of the diurnal rhythm of drinking, employing electrical lickometers, detected no difference between the rhythms of 4 rats with ibotenate lesions of the MnPO who failed to drink to homeostatic challenges and 4 vehicle-injected control rats. The results indicate that ibotenic acid lesions of the MnPO block drinking behavior stimulated by angiotensin II and hypertonic saline without disrupting the entrainment or pattern of ad libitum drinking.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1504809     DOI: 10.1016/0006-8993(92)90961-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  20 in total

Review 1.  Neurohumoral Integration of Cardiovascular Function by the Lamina Terminalis.

Authors:  Nicole M Cancelliere; Emily A E Black; Alastair V Ferguson
Journal:  Curr Hypertens Rep       Date:  2015-12       Impact factor: 5.369

2.  Efferent projections from the median preoptic nucleus to sleep- and arousal-regulatory nuclei in the rat brain.

Authors:  A Uschakov; H Gong; D McGinty; R Szymusiak
Journal:  Neuroscience       Date:  2007-09-12       Impact factor: 3.590

3.  Intrinsic properties of the sodium sensor neurons in the rat median preoptic nucleus.

Authors:  Aurore N Voisin; Guy Drolet; Didier Mouginot
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-08-08       Impact factor: 3.619

4.  Median preoptic neurones projecting to the hypothalamic paraventricular nucleus respond to osmotic, circulating Ang II and baroreceptor input in the rat.

Authors:  Sean D Stocker; Glenn M Toney
Journal:  J Physiol       Date:  2005-08-04       Impact factor: 5.182

5.  Increased dietary sodium alters Fos expression in the lamina terminalis during intravenous angiotensin II infusion.

Authors:  Steven L Bealer; Cameron S Metcalf; Ryan Heyborne
Journal:  Exp Neurol       Date:  2007-01-09       Impact factor: 5.330

6.  Reciprocal Control of Drinking Behavior by Median Preoptic Neurons in Mice.

Authors:  Stephen B G Abbott; Natalia L S Machado; Joel C Geerling; Clifford B Saper
Journal:  J Neurosci       Date:  2016-08-03       Impact factor: 6.167

7.  Median preoptic glutamatergic neurons promote thermoregulatory heat loss and water consumption in mice.

Authors:  Stephen B G Abbott; Clifford B Saper
Journal:  J Physiol       Date:  2017-09-13       Impact factor: 5.182

8.  Brain angiotensin type-1 and type-2 receptors: cellular locations under normal and hypertensive conditions.

Authors:  Colin Sumners; Amy Alleyne; Vermalí Rodríguez; David J Pioquinto; Jacob A Ludin; Shormista Kar; Zachary Winder; Yuma Ortiz; Meng Liu; Eric G Krause; Annette D de Kloet
Journal:  Hypertens Res       Date:  2019-12-18       Impact factor: 3.872

9.  Role of the Median Preoptic Nucleus in Arterial Pressure Regulation and Sodium and Water Homeostasis during High Dietary Salt Intake.

Authors:  T Ployngam; S S Katz; J P Collister
Journal:  Neurophysiology       Date:  2012-10-31       Impact factor: 0.587

Review 10.  A role for benzamil-sensitive proteins of the central nervous system in the pathogenesis of salt-dependent hypertension.

Authors:  Joanna M Abrams; John W Osborn
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-05       Impact factor: 2.557

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.